Abstract: INFO15-TH
Announcement of National Center Biobank Network (NCBN) in Japan
Session Information
- Informational Posters - I
November 07, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Pathology and Lab Medicine
- No subcategory defined
Author
- Noiri, Eisei, NCGM, Tokyo, Japan
Group or Team Name
- National Center Biobank Network (Japan)
Description
The National Center Biobank Network (NCBN) in Japan developed in 2011 aiming to enhance the utilization of biospecimen and expand the precision medicine and research in academic institutions and pharmaceutical companies. Japan has six National Centers (NCs) which are in charge of advanced and specialized medical cares and researches to explore and overcome the burden diseases that would have a significant impact on the national health. Each NC established a biobank to store biospecimens of various diseases based on the specialty of NC. However, the utilization of biospecimens were limited in the NC clinical research or collaborative work. NCBN promote the utilization of the biospecimens in the various research not only academic institutions but also the pharmaceutical companies which would have a highly valuable for the development of new drug, diagnostic test and the achievement of personalized medicine. NCBN is coordinating 6 biobanks; cancer-related biobank, cardiovascular diseases-related biobank, neurology and psychiatry-related biobank, infectious diseases and immune disorder-related biobank, child health-related biobank and geriatric diseases-related biobank. Diseases-related biospecimens from variety of diseases are collecting. 237,251 biospecimens including the tissue specimens from 74,041 patients of more than 220 diseases were stored in 6 biobanks between 2012 and 2018. Quality of diagnosis highest and sample management quaity is also highest. The distribution record is also highest in Japan. Visit to "ncbiobank.org".
Funding
- Ministry of Health, Labour and Welfare (Japan)